カテゴリ： 世界, 医療/バイオ, QYResearch

即効性喘息治療薬の世界市場2023年：錠剤、スプレー

■ 英語タイトル：Global Quick-acting Asthma Medicine Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA1829）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA1829
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：89
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[即効性喘息治療薬の世界市場2023年：錠剤、スプレー]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は即効性喘息治療薬のグローバル市場について調査・分析し、世界の即効性喘息治療薬市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（錠剤、スプレー）、用途別セグメント分析（病院薬局、オンライン薬局、小売薬局）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Pfizer、GlaxoSmithKline、Novartis、Merck、Boehringer Ingelheim、AstraZeneca、Roche、Teva Pharmaceutical、Vectura Groupなどが含まれています。即効性喘息治療薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、即効性喘息治療薬市場規模を算出する際に考慮しました。

・即効性喘息治療薬市場の概要
- 製品の定義
- 即効性喘息治療薬の種類別セグメント
- 世界の即効性喘息治療薬市場規模：タイプ別分析（錠剤、スプレー）
- 即効性喘息治療薬の用途別セグメント
- 世界の即効性喘息治療薬市場規模：用途別分析（病院薬局、オンライン薬局、小売薬局）
- 世界の即効性喘息治療薬市場規模予測（2018年-2029年）
- 即効性喘息治療薬の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 即効性喘息治療薬市場の競争状況およびトレンド

・即効性喘息治療薬の地域別市場規模
- 北米の即効性喘息治療薬市場規模（2018年-2029年）
- 米国の即効性喘息治療薬市場規模（2018年-2029年）
- ヨーロッパの即効性喘息治療薬市場規模（2018年-2029年）
- アジア太平洋の即効性喘息治療薬市場規模（2018年-2029年）
- 中国の即効性喘息治療薬市場規模（2018年-2029年）
- 日本の即効性喘息治療薬市場規模（2018年-2029年）
- 韓国の即効性喘息治療薬市場規模（2018年-2029年）
- インドの即効性喘息治療薬市場規模（2018年-2029年）
- オーストラリアの即効性喘息治療薬市場規模（2018年-2029年）
- 中南米の即効性喘息治療薬市場規模（2018年-2029年）
- 中東・アフリカの即効性喘息治療薬市場規模（2018年-2029年）

・種類別セグメント：錠剤、スプレー
- 世界の即効性喘息治療薬のタイプ別販売量（2018年-2023年）
- 世界の即効性喘息治療薬のタイプ別売上（2018年-2023年）
- 世界の即効性喘息治療薬のタイプ別価格

・用途別セグメント：病院薬局、オンライン薬局、小売薬局
- 世界の即効性喘息治療薬の用途別販売量（2018年-2023年）
- 世界の即効性喘息治療薬の用途別売上（2018年-2023年）
- 世界の即効性喘息治療薬の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Pfizer、GlaxoSmithKline、Novartis、Merck、Boehringer Ingelheim、AstraZeneca、Roche、Teva Pharmaceutical、Vectura Group

・産業チェーンと販売チャネルの分析
- 即効性喘息治療薬産業チェーン分析
- 即効性喘息治療薬の主要原材料
- 即効性喘息治療薬の販売チャネル
- 即効性喘息治療薬のディストリビューター
- 即効性喘息治療薬の主要顧客

・即効性喘息治療薬市場ダイナミクス
- 即効性喘息治療薬の業界動向
- 即効性喘息治療薬市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Quick-acting Asthma Medicine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Quick-acting Asthma Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Quick-acting Asthma Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Quick-acting Asthma Medicine include Pfizer, GlaxoSmithKline, Novartis, Merck, Boehringer Ingelheim, AstraZeneca, Roche, Teva Pharmaceutical and Vectura Group, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Quick-acting Asthma Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quick-acting Asthma Medicine.
The Quick-acting Asthma Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Quick-acting Asthma Medicine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Quick-acting Asthma Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Pfizer
GlaxoSmithKline
Novartis
Merck
Boehringer Ingelheim
AstraZeneca
Roche
Teva Pharmaceutical
Vectura Group
Segment by Type
Tablet
Spray
Segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Quick-acting Asthma Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Quick-acting Asthma Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Quick-acting Asthma Medicine Market Overview
1.1 Product Overview and Scope of Quick-acting Asthma Medicine
1.2 Quick-acting Asthma Medicine Segment by Type
1.2.1 Global Quick-acting Asthma Medicine Market Value Comparison by Type (2023-2029)
1.2.2 Tablet
1.2.3 Spray
1.3 Quick-acting Asthma Medicine Segment by Application
1.3.1 Global Quick-acting Asthma Medicine Market Value by Application: (2023-2029)
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Global Quick-acting Asthma Medicine Market Size Estimates and Forecasts
1.4.1 Global Quick-acting Asthma Medicine Revenue 2018-2029
1.4.2 Global Quick-acting Asthma Medicine Sales 2018-2029
1.4.3 Global Quick-acting Asthma Medicine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Quick-acting Asthma Medicine Market Competition by Manufacturers
2.1 Global Quick-acting Asthma Medicine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Quick-acting Asthma Medicine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Quick-acting Asthma Medicine Average Price by Manufacturers (2018-2023)
2.4 Global Quick-acting Asthma Medicine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Quick-acting Asthma Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Quick-acting Asthma Medicine, Product Type & Application
2.7 Quick-acting Asthma Medicine Market Competitive Situation and Trends
2.7.1 Quick-acting Asthma Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Quick-acting Asthma Medicine Players Market Share by Revenue
2.7.3 Global Quick-acting Asthma Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Quick-acting Asthma Medicine Retrospective Market Scenario by Region
3.1 Global Quick-acting Asthma Medicine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Quick-acting Asthma Medicine Global Quick-acting Asthma Medicine Sales by Region: 2018-2029
3.2.1 Global Quick-acting Asthma Medicine Sales by Region: 2018-2023
3.2.2 Global Quick-acting Asthma Medicine Sales by Region: 2024-2029
3.3 Global Quick-acting Asthma Medicine Global Quick-acting Asthma Medicine Revenue by Region: 2018-2029
3.3.1 Global Quick-acting Asthma Medicine Revenue by Region: 2018-2023
3.3.2 Global Quick-acting Asthma Medicine Revenue by Region: 2024-2029
3.4 North America Quick-acting Asthma Medicine Market Facts & Figures by Country
3.4.1 North America Quick-acting Asthma Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Quick-acting Asthma Medicine Sales by Country (2018-2029)
3.4.3 North America Quick-acting Asthma Medicine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Quick-acting Asthma Medicine Market Facts & Figures by Country
3.5.1 Europe Quick-acting Asthma Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Quick-acting Asthma Medicine Sales by Country (2018-2029)
3.5.3 Europe Quick-acting Asthma Medicine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Quick-acting Asthma Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Quick-acting Asthma Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Quick-acting Asthma Medicine Sales by Country (2018-2029)
3.6.3 Asia Pacific Quick-acting Asthma Medicine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Quick-acting Asthma Medicine Market Facts & Figures by Country
3.7.1 Latin America Quick-acting Asthma Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Quick-acting Asthma Medicine Sales by Country (2018-2029)
3.7.3 Latin America Quick-acting Asthma Medicine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Quick-acting Asthma Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Quick-acting Asthma Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Quick-acting Asthma Medicine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Quick-acting Asthma Medicine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Quick-acting Asthma Medicine Sales by Type (2018-2029)
4.1.1 Global Quick-acting Asthma Medicine Sales by Type (2018-2023)
4.1.2 Global Quick-acting Asthma Medicine Sales by Type (2024-2029)
4.1.3 Global Quick-acting Asthma Medicine Sales Market Share by Type (2018-2029)
4.2 Global Quick-acting Asthma Medicine Revenue by Type (2018-2029)
4.2.1 Global Quick-acting Asthma Medicine Revenue by Type (2018-2023)
4.2.2 Global Quick-acting Asthma Medicine Revenue by Type (2024-2029)
4.2.3 Global Quick-acting Asthma Medicine Revenue Market Share by Type (2018-2029)
4.3 Global Quick-acting Asthma Medicine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Quick-acting Asthma Medicine Sales by Application (2018-2029)
5.1.1 Global Quick-acting Asthma Medicine Sales by Application (2018-2023)
5.1.2 Global Quick-acting Asthma Medicine Sales by Application (2024-2029)
5.1.3 Global Quick-acting Asthma Medicine Sales Market Share by Application (2018-2029)
5.2 Global Quick-acting Asthma Medicine Revenue by Application (2018-2029)
5.2.1 Global Quick-acting Asthma Medicine Revenue by Application (2018-2023)
5.2.2 Global Quick-acting Asthma Medicine Revenue by Application (2024-2029)
5.2.3 Global Quick-acting Asthma Medicine Revenue Market Share by Application (2018-2029)
5.3 Global Quick-acting Asthma Medicine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Quick-acting Asthma Medicine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GlaxoSmithKline Quick-acting Asthma Medicine Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novartis Quick-acting Asthma Medicine Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck Quick-acting Asthma Medicine Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Boehringer Ingelheim Quick-acting Asthma Medicine Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 AstraZeneca Quick-acting Asthma Medicine Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Roche Quick-acting Asthma Medicine Product Portfolio
6.7.5 Roche Recent Developments/Updates
6.8 Teva Pharmaceutical
6.8.1 Teva Pharmaceutical Corporation Information
6.8.2 Teva Pharmaceutical Description and Business Overview
6.8.3 Teva Pharmaceutical Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Teva Pharmaceutical Quick-acting Asthma Medicine Product Portfolio
6.8.5 Teva Pharmaceutical Recent Developments/Updates
6.9 Vectura Group
6.9.1 Vectura Group Corporation Information
6.9.2 Vectura Group Description and Business Overview
6.9.3 Vectura Group Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Vectura Group Quick-acting Asthma Medicine Product Portfolio
6.9.5 Vectura Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Quick-acting Asthma Medicine Industry Chain Analysis
7.2 Quick-acting Asthma Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Quick-acting Asthma Medicine Production Mode & Process
7.4 Quick-acting Asthma Medicine Sales and Marketing
7.4.1 Quick-acting Asthma Medicine Sales Channels
7.4.2 Quick-acting Asthma Medicine Distributors
7.5 Quick-acting Asthma Medicine Customers
8 Quick-acting Asthma Medicine Market Dynamics
8.1 Quick-acting Asthma Medicine Industry Trends
8.2 Quick-acting Asthma Medicine Market Drivers
8.3 Quick-acting Asthma Medicine Market Challenges
8.4 Quick-acting Asthma Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Quick-acting Asthma Medicine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Quick-acting Asthma Medicine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Quick-acting Asthma Medicine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Quick-acting Asthma Medicine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Quick-acting Asthma Medicine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Quick-acting Asthma Medicine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Quick-acting Asthma Medicine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Quick-acting Asthma Medicine Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Quick-acting Asthma Medicine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Quick-acting Asthma Medicine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Quick-acting Asthma Medicine, Product Type & Application
Table 12. Global Key Manufacturers of Quick-acting Asthma Medicine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Quick-acting Asthma Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quick-acting Asthma Medicine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Quick-acting Asthma Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Quick-acting Asthma Medicine Sales by Region (2018-2023) & (K Units)
Table 18. Global Quick-acting Asthma Medicine Sales Market Share by Region (2018-2023)
Table 19. Global Quick-acting Asthma Medicine Sales by Region (2024-2029) & (K Units)
Table 20. Global Quick-acting Asthma Medicine Sales Market Share by Region (2024-2029)
Table 21. Global Quick-acting Asthma Medicine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Quick-acting Asthma Medicine Revenue Market Share by Region (2018-2023)
Table 23. Global Quick-acting Asthma Medicine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Quick-acting Asthma Medicine Revenue Market Share by Region (2024-2029)
Table 25. North America Quick-acting Asthma Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Quick-acting Asthma Medicine Sales by Country (2018-2023) & (K Units)
Table 27. North America Quick-acting Asthma Medicine Sales by Country (2024-2029) & (K Units)
Table 28. North America Quick-acting Asthma Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Quick-acting Asthma Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Quick-acting Asthma Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Quick-acting Asthma Medicine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Quick-acting Asthma Medicine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Quick-acting Asthma Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Quick-acting Asthma Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Quick-acting Asthma Medicine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Quick-acting Asthma Medicine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Quick-acting Asthma Medicine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Quick-acting Asthma Medicine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Quick-acting Asthma Medicine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Quick-acting Asthma Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Quick-acting Asthma Medicine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Quick-acting Asthma Medicine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Quick-acting Asthma Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Quick-acting Asthma Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Quick-acting Asthma Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Quick-acting Asthma Medicine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Quick-acting Asthma Medicine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Quick-acting Asthma Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Quick-acting Asthma Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Quick-acting Asthma Medicine Sales (K Units) by Type (2018-2023)
Table 51. Global Quick-acting Asthma Medicine Sales (K Units) by Type (2024-2029)
Table 52. Global Quick-acting Asthma Medicine Sales Market Share by Type (2018-2023)
Table 53. Global Quick-acting Asthma Medicine Sales Market Share by Type (2024-2029)
Table 54. Global Quick-acting Asthma Medicine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Quick-acting Asthma Medicine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Quick-acting Asthma Medicine Revenue Market Share by Type (2018-2023)
Table 57. Global Quick-acting Asthma Medicine Revenue Market Share by Type (2024-2029)
Table 58. Global Quick-acting Asthma Medicine Price (USD/Unit) by Type (2018-2023)
Table 59. Global Quick-acting Asthma Medicine Price (USD/Unit) by Type (2024-2029)
Table 60. Global Quick-acting Asthma Medicine Sales (K Units) by Application (2018-2023)
Table 61. Global Quick-acting Asthma Medicine Sales (K Units) by Application (2024-2029)
Table 62. Global Quick-acting Asthma Medicine Sales Market Share by Application (2018-2023)
Table 63. Global Quick-acting Asthma Medicine Sales Market Share by Application (2024-2029)
Table 64. Global Quick-acting Asthma Medicine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Quick-acting Asthma Medicine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Quick-acting Asthma Medicine Revenue Market Share by Application (2018-2023)
Table 67. Global Quick-acting Asthma Medicine Revenue Market Share by Application (2024-2029)
Table 68. Global Quick-acting Asthma Medicine Price (USD/Unit) by Application (2018-2023)
Table 69. Global Quick-acting Asthma Medicine Price (USD/Unit) by Application (2024-2029)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Quick-acting Asthma Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Pfizer Quick-acting Asthma Medicine Product
Table 74. Pfizer Recent Developments/Updates
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Business Overview
Table 77. GlaxoSmithKline Quick-acting Asthma Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. GlaxoSmithKline Quick-acting Asthma Medicine Product
Table 79. GlaxoSmithKline Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Quick-acting Asthma Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Novartis Quick-acting Asthma Medicine Product
Table 84. Novartis Recent Developments/Updates
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Quick-acting Asthma Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Merck Quick-acting Asthma Medicine Product
Table 89. Merck Recent Developments/Updates
Table 90. Boehringer Ingelheim Corporation Information
Table 91. Boehringer Ingelheim Description and Business Overview
Table 92. Boehringer Ingelheim Quick-acting Asthma Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Boehringer Ingelheim Quick-acting Asthma Medicine Product
Table 94. Boehringer Ingelheim Recent Developments/Updates
Table 95. AstraZeneca Corporation Information
Table 96. AstraZeneca Description and Business Overview
Table 97. AstraZeneca Quick-acting Asthma Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. AstraZeneca Quick-acting Asthma Medicine Product
Table 99. AstraZeneca Recent Developments/Updates
Table 100. Roche Corporation Information
Table 101. Roche Description and Business Overview
Table 102. Roche Quick-acting Asthma Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Roche Quick-acting Asthma Medicine Product
Table 104. Roche Recent Developments/Updates
Table 105. Teva Pharmaceutical Corporation Information
Table 106. Teva Pharmaceutical Description and Business Overview
Table 107. Teva Pharmaceutical Quick-acting Asthma Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Teva Pharmaceutical Quick-acting Asthma Medicine Product
Table 109. Teva Pharmaceutical Recent Developments/Updates
Table 110. Vectura Group Corporation Information
Table 111. Vectura Group Description and Business Overview
Table 112. Vectura Group Quick-acting Asthma Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Vectura Group Quick-acting Asthma Medicine Product
Table 114. Vectura Group Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Quick-acting Asthma Medicine Distributors List
Table 118. Quick-acting Asthma Medicine Customers List
Table 119. Quick-acting Asthma Medicine Market Trends
Table 120. Quick-acting Asthma Medicine Market Drivers
Table 121. Quick-acting Asthma Medicine Market Challenges
Table 122. Quick-acting Asthma Medicine Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Quick-acting Asthma Medicine
Figure 2. Global Quick-acting Asthma Medicine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Quick-acting Asthma Medicine Market Share by Type in 2022 & 2029
Figure 4. Tablet Product Picture
Figure 5. Spray Product Picture
Figure 6. Global Quick-acting Asthma Medicine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Quick-acting Asthma Medicine Market Share by Application in 2022 & 2029
Figure 8. Hospital Pharmacy
Figure 9. Online Pharmacy
Figure 10. Retail Pharmacy
Figure 11. Global Quick-acting Asthma Medicine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Quick-acting Asthma Medicine Market Size (2018-2029) & (US$ Million)
Figure 13. Global Quick-acting Asthma Medicine Sales (2018-2029) & (K Units)
Figure 14. Global Quick-acting Asthma Medicine Average Price (USD/Unit) & (2018-2029)
Figure 15. Quick-acting Asthma Medicine Report Years Considered
Figure 16. Quick-acting Asthma Medicine Sales Share by Manufacturers in 2022
Figure 17. Global Quick-acting Asthma Medicine Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Quick-acting Asthma Medicine Players: Market Share by Revenue in 2022
Figure 19. Quick-acting Asthma Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Quick-acting Asthma Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Quick-acting Asthma Medicine Sales Market Share by Country (2018-2029)
Figure 22. North America Quick-acting Asthma Medicine Revenue Market Share by Country (2018-2029)
Figure 23. United States Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Quick-acting Asthma Medicine Sales Market Share by Country (2018-2029)
Figure 26. Europe Quick-acting Asthma Medicine Revenue Market Share by Country (2018-2029)
Figure 27. Germany Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Quick-acting Asthma Medicine Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Quick-acting Asthma Medicine Revenue Market Share by Region (2018-2029)
Figure 34. China Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Quick-acting Asthma Medicine Sales Market Share by Country (2018-2029)
Figure 44. Latin America Quick-acting Asthma Medicine Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Quick-acting Asthma Medicine Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Quick-acting Asthma Medicine Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Quick-acting Asthma Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Quick-acting Asthma Medicine by Type (2018-2029)
Figure 54. Global Revenue Market Share of Quick-acting Asthma Medicine by Type (2018-2029)
Figure 55. Global Quick-acting Asthma Medicine Price (USD/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Quick-acting Asthma Medicine by Application (2018-2029)
Figure 57. Global Revenue Market Share of Quick-acting Asthma Medicine by Application (2018-2029)
Figure 58. Global Quick-acting Asthma Medicine Price (USD/Unit) by Application (2018-2029)
Figure 59. Quick-acting Asthma Medicine Value Chain
Figure 60. Quick-acting Asthma Medicine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 湿疹ケア用品の世界市場2023年：クリーム、軟膏、化粧水、保湿剤、スプレー、その他（バームなど）
  • 食品用除菌剤の世界市場2023年：スプレー、ダンプ
  • 口腔乾燥症治療薬のグローバル市場展望 2023年-2029年：スプレー、内服液、口腔錠、マウスウォッシュ
  • 皮膚創傷洗浄剤のグローバル市場展望 2023年-2029年：スプレー、ワイプ、フォーム、その他
  • ドライマウス治療薬のグローバル市場展望 2023年-2029年：マウスウォッシュ、スプレー、トローチ、ジェル、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA1829 )"即効性喘息治療薬の世界市場2023年：錠剤、スプレー" (英文：Global Quick-acting Asthma Medicine Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。